Pharmacy Doctor, Fudan University,

Research and investment in the field of anti-tumor drugs,

Experiences in consulting and healthcare investment,

Overseas mergers and acquisitions & innovative drug investment

Postdoctoral from Stanford University, former head of competitive intelligence and strategy in Novartis, Over 20 years of pharmaceutical industry research experience

Doctor of chemistry, University of Manchester,  Research and investment in innovative drugs & surgical robots, Several cases in innovative drugs and medical devices investment

M.D., MSc of health economics from Johns Hopkins University,

Investment in innovative drugs from the perspective of clinical needs, Work experiences in WHO headquarters and global leading healthcare information, R&D service enterprise

Postdoctoral from Harvard Univ. Applied 4 Chinese patents and published 16 SCI papers,

Specializes in drug discovery,  nuclear medicine and molecular imaging.

Doctor from Cambridge University and Jilin University,

Specialized in research and investment of innovative drugs

Member of Guangdong pharmacological society and Anti-tumor Drug Professional Committee

Organic chemistry Ph.D. from Cambridge University

Shenzhen Peacock Talent

Over 10 years of drug research, specializes total synthesis of natural products and drugs

MSc of Biology, Sun Yat-Sen University, Focuses on gene, cell therapy, high-end medical device research and investment, many years of VC/PE investment experience, with > 10 successful investment cases, including 3 IPO projects

MSc from Sun Yat-Sen University & Kansai University, with molecular biology and financial background, work experience in top biomedical investment firm

BSc from Shanghai Jiaotong University with law background,
former invest manager in ZhongCai Financial Holding & ZCT

Ph.D. from Oxford University,

CFA candidate, work experience in biomedical research, doctoral start-up program won first prize in UK